80_FR_15071 80 FR 15017 - Pediatric Stakeholder Meeting; Request for Comments; Correction

80 FR 15017 - Pediatric Stakeholder Meeting; Request for Comments; Correction

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Federal Register Volume 80, Issue 54 (March 20, 2015)

Page Range15017-15017
FR Document2015-06426

The Food and Drug Administration is correcting a document entitled ``Pediatric Stakeholder Meeting; Request for Comments'' that appeared in the Federal Register of February 26, 2015 (80 FR 10493). The document announced a public meeting seeking input from patient groups, consumer groups, regulated industry, academia and other interested parties to obtain any recommendations or information relevant to the report to Congress that FDA is required to submit concerning pediatrics, as outlined in the Food and Drug Administration Safety and Innovation Act (FDASIA). The document was published with the incorrect docket number. This document corrects that error.

Federal Register, Volume 80 Issue 54 (Friday, March 20, 2015)
[Federal Register Volume 80, Number 54 (Friday, March 20, 2015)]
[Notices]
[Page 15017]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-06426]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2015-N-0456]


Pediatric Stakeholder Meeting; Request for Comments; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration is correcting a document 
entitled ``Pediatric Stakeholder Meeting; Request for Comments'' that 
appeared in the Federal Register of February 26, 2015 (80 FR 10493). 
The document announced a public meeting seeking input from patient 
groups, consumer groups, regulated industry, academia and other 
interested parties to obtain any recommendations or information 
relevant to the report to Congress that FDA is required to submit 
concerning pediatrics, as outlined in the Food and Drug Administration 
Safety and Innovation Act (FDASIA). The document was published with the 
incorrect docket number. This document corrects that error.

FOR FURTHER INFORMATION CONTACT: Lisa Granger, Office of Policy, 
Planning, Legislation, and Analysis, Food and Drug Administration, 
10903 New Hampshire Ave., Bldg. 32, Rm. 3330, Silver Spring, MD 20993, 
301-796-9115.

SUPPLEMENTARY INFORMATION: In the Federal Register of February 26, 
2015, in FR Doc. 2015-03974, on page 10493, the following correction is 
made:
    On page 10493, in the first column, the Docket No. heading, 
``[Docket No. FDA-20115-N-0456]'' is corrected to read ``[Docket No. 
FDA-2015-N-0456]''.

    Dated: March 17, 2015.
Jill Hartzler Warner,
Associate Commissioner for Special Medical Programs.
[FR Doc. 2015-06426 Filed 3-19-15; 8:45 am]
 BILLING CODE 4164-01-P



                                                                                  Federal Register / Vol. 80, No. 54 / Friday, March 20, 2015 / Notices                                                 15017

                                                    Estimated Total Annual Burden                         and other interested parties to obtain                individual investigators, the disclosure
                                                  Hours: 14,505.                                          any recommendations or information                    of which would constitute a clearly
                                                    In compliance with the requirements                   relevant to the report to Congress that               unwarranted invasion of personal
                                                  of section 3506(c)(2)(A) of the                         FDA is required to submit concerning                  privacy.
                                                  Paperwork Reduction Act of 1995, the                    pediatrics, as outlined in the Food and                 Name of Committee: Board of Scientific
                                                  Administration for Children and                         Drug Administration Safety and                        Counselors, NIDDK.
                                                  Families is soliciting public comment                   Innovation Act (FDASIA). The                            Date: April 15–16, 2015.
                                                  on the specific aspects of the                          document was published with the                         Open: April 15, 2015, 8:00 a.m. to 8:15 a.m.
                                                  information collection described above.                 incorrect docket number. This                           Agenda: Introductions and Overview.
                                                  Copies of the proposed collection of                    document corrects that error.                           Place: National Institutes of Health,
                                                                                                                                                                Building 5, Room 127, 5 Memorial Drive,
                                                  information can be obtained and                         FOR FURTHER INFORMATION CONTACT: Lisa                 Bethesda, MD 20892.
                                                  comments may be forwarded by writing                    Granger, Office of Policy, Planning,                    Closed: April 15, 2015, 8:15 a.m. to 6:05
                                                  to the Administration for Children and                  Legislation, and Analysis, Food and                   p.m.
                                                  Families, Office of Planning, Research                  Drug Administration, 10903 New                          Agenda: To review and evaluate personal
                                                  and Evaluation, 370 L’Enfant                            Hampshire Ave., Bldg. 32, Rm. 3330,                   qualifications and performance, and
                                                  Promenade SW., Washington, DC 20447,                    Silver Spring, MD 20993, 301–796–                     competence of individual investigators.
                                                  Attn: OPRE Reports Clearance Officer.                   9115.                                                   Place: National Institutes of Health,
                                                  Email address: OPREinfocollection@                                                                            Building 5, Room 127, 5 Memorial Drive,
                                                  acf.hhs.gov. All requests should be                     SUPPLEMENTARY INFORMATION:     In the                 Bethesda, MD 20892.
                                                                                                          Federal Register of February 26, 2015,                  Closed: April 16, 2015, 8:00 a.m. to 4:30
                                                  identified by the title of the information                                                                    p.m.
                                                  collection.                                             in FR Doc. 2015–03974, on page 10493,
                                                                                                          the following correction is made:                       Agenda: To review and evaluate personal
                                                    The Department specifically requests                                                                        qualifications and performance, and
                                                  comments on (a) whether the proposed                      On page 10493, in the first column,
                                                                                                                                                                competence of individual investigators.
                                                  collection of information is necessary                  the Docket No. heading, ‘‘[Docket No.                   Place: National Institutes of Health,
                                                  for the proper performance of the                       FDA–20115–N–0456]’’ is corrected to                   Building 5, Room 127, 5 Memorial Drive,
                                                  functions of the agency, including                      read ‘‘[Docket No. FDA–2015–N–0456]’’.                Bethesda, MD 20892.
                                                  whether the information shall have                         Dated: March 17, 2015.                               Contact Person: Michael W. Krause, Ph.D.,
                                                  practical utility; (b) the accuracy of the              Jill Hartzler Warner,                                 Scientific Director, National Institute of
                                                                                                                                                                Diabetes and Digestive and Kidney Diseases,
                                                  agency’s estimate of the burden of the                  Associate Commissioner for Special Medical            National Institute of Health, Building 5,
                                                  proposed collection of information; (c)                 Programs.                                             Room B104, Bethesda, MD 20892–1818, (301)
                                                  the quality, utility, and clarity of the                [FR Doc. 2015–06426 Filed 3–19–15; 8:45 am]           402–4633, mwkrause@helix.nih.gov.
                                                  information to be collected; and (d)                    BILLING CODE 4164–01–P                                (Catalogue of Federal Domestic Assistance
                                                  ways to minimize the burden of the                                                                            Program Nos. 93.847, Diabetes,
                                                  collection of information on                                                                                  Endocrinology and Metabolic Research;
                                                  respondents, including through the use                  DEPARTMENT OF HEALTH AND                              93.848, Digestive Diseases and Nutrition
                                                  of automated collection techniques or                   HUMAN SERVICES                                        Research; 93.849, Kidney Diseases, Urology
                                                  other forms of information technology.                                                                        and Hematology Research, National Institutes
                                                  Consideration will be given to                          National Institutes of Health                         of Health, HHS)
                                                  comments and suggestions submitted                                                                              Dated: March 13, 2015.
                                                  within 60 days of this publication.                     National Institute of Diabetes and
                                                                                                                                                                David Clary,
                                                                                                          Digestive and Kidney Diseases; Notice
                                                  Karl Koerper,                                           of Meeting                                            Program Analyst, Office of Federal Advisory
                                                                                                                                                                Committee Policy.
                                                  Reports Clearance Officer.
                                                                                                             Pursuant to section 10(d) of the                   [FR Doc. 2015–06346 Filed 3–19–15; 8:45 am]
                                                  [FR Doc. 2015–06385 Filed 3–19–15; 8:45 am]
                                                                                                          Federal Advisory Committee Act, as                    BILLING CODE 4140–01–P
                                                  BILLING CODE 4184–22–P
                                                                                                          amended (5 U.S.C. App.), notice is
                                                                                                          hereby given of a meeting of the Board
                                                                                                          of Scientific Counselors, NIDDK.                      DEPARTMENT OF HEALTH AND
                                                  DEPARTMENT OF HEALTH AND
                                                                                                             The meeting will be open to the                    HUMAN SERVICES
                                                  HUMAN SERVICES
                                                                                                          public as indicated below, with
                                                                                                          attendance limited to space available.                National Institutes of Health
                                                  Food and Drug Administration
                                                                                                          Individuals who plan to attend and
                                                  [Docket No. FDA–2015–N–0456]                                                                                  National Institute on Drug Abuse
                                                                                                          need special assistance, such as sign
                                                                                                                                                                Notice of Closed Meeting
                                                                                                          language interpretation or other
                                                  Pediatric Stakeholder Meeting;
                                                                                                          reasonable accommodations, should                       Pursuant to section 10(d) of the
                                                  Request for Comments; Correction
                                                                                                          notify the Contact Person listed below                Federal Advisory Committee Act, as
                                                  AGENCY:    Food and Drug Administration,                in advance of the meeting.                            amended (5 U.S.C. App.), notice is
                                                  HHS.                                                       The meeting will be closed to the                  hereby given of the following meeting.
                                                  ACTION:   Notice; correction.                           public as indicated below in accordance                 The meeting will be closed to the
                                                                                                          with the provisions set forth in section              public in accordance with the
                                                  SUMMARY:    The Food and Drug                           552b(c)(6), Title 5 U.S.C., as amended                provisions set forth in sections
mstockstill on DSK4VPTVN1PROD with NOTICES




                                                  Administration is correcting a document                 for the review, discussion, and                       552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
                                                  entitled ‘‘Pediatric Stakeholder Meeting;               evaluation of individual intramural                   as amended. The contract proposals and
                                                  Request for Comments’’ that appeared in                 programs and projects conducted by the                the discussions could disclose
                                                  the Federal Register of February 26,                    NATIONAL INSTITUTE OF DIABETES                        confidential trade secrets or commercial
                                                  2015 (80 FR 10493). The document                        AND DIGESTIVE AND KIDNEY                              property such as patentable material,
                                                  announced a public meeting seeking                      DISEASES, including consideration of                  and personal information concerning
                                                  input from patient groups, consumer                     personnel qualifications and                          individuals associated with the contract
                                                  groups, regulated industry, academia                    performance, and the competence of                    proposals, the disclosure of which


                                             VerDate Sep<11>2014   20:14 Mar 19, 2015   Jkt 235001   PO 00000   Frm 00113   Fmt 4703   Sfmt 4703   E:\FR\FM\20MRN1.SGM   20MRN1



Document Created: 2015-12-18 11:34:12
Document Modified: 2015-12-18 11:34:12
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice; correction.
ContactLisa Granger, Office of Policy, Planning, Legislation, and Analysis, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 3330, Silver Spring, MD 20993, 301-796-9115.
FR Citation80 FR 15017 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR